These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38926405)

  • 1. A retrospective study of the MDS criteria for prodromal Parkinson's disease in the general population.
    de Klerk GW; van Laar T; Meles SK
    NPJ Parkinsons Dis; 2024 Jun; 10(1):125. PubMed ID: 38926405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Prodromal Parkinson's Disease as Defined by MDS Research Criteria among Elderly Patients Undergoing Colonoscopy.
    Skorvanek M; Ladomirjakova Z; Han V; Lesko N; Feketeova E; Jarcuskova D; Repkova B; Spisak P; Urbancikova Z; Vargova A; Gombosova L; Zakuciova M; Veseliny E; Trebuna F; Mechirova E; Gdovinova Z
    J Parkinsons Dis; 2017; 7(3):481-489. PubMed ID: 28387681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronally Derived Extracellular Vesicle α-Synuclein as a Serum Biomarker for Individuals at Risk of Developing Parkinson Disease.
    Yan S; Jiang C; Janzen A; Barber TR; Seger A; Sommerauer M; Davis JJ; Marek K; Hu MT; Oertel WH; Tofaris GK
    JAMA Neurol; 2024 Jan; 81(1):59-68. PubMed ID: 38048087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the MDS research criteria for prodromal Parkinson's disease: Longitudinal assessment in a REM sleep behavior disorder (RBD) cohort.
    Fereshtehnejad SM; Montplaisir JY; Pelletier A; Gagnon JF; Berg D; Postuma RB
    Mov Disord; 2017 Jun; 32(6):865-873. PubMed ID: 28429825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of the movement disorder society prodromal Parkinson's disease research criteria in 2 independent prospective cohorts.
    Pilotto A; Heinzel S; Suenkel U; Lerche S; Brockmann K; Roeben B; Schaeffer E; Wurster I; Yilmaz R; Liepelt-Scarfone I; von Thaler AK; Metzger FG; Eschweiler GW; Postuma RB; Maetzler W; Berg D
    Mov Disord; 2017 Jul; 32(7):1025-1034. PubMed ID: 28509336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prodromal Parkinson's disease as defined per MDS research criteria in the general elderly community.
    Mahlknecht P; Gasperi A; Willeit P; Kiechl S; Stockner H; Willeit J; Rungger G; Sawires M; Nocker M; Rastner V; Mair KJ; Hotter A; Poewe W; Seppi K
    Mov Disord; 2016 Sep; 31(9):1405-8. PubMed ID: 27273736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of the Movement Disorders Society criteria for prodromal Parkinson's disease: A population-based 10-year study.
    Mahlknecht P; Gasperi A; Djamshidian A; Kiechl S; Stockner H; Willeit P; Willeit J; Rungger G; Poewe W; Seppi K
    Mov Disord; 2018 Mar; 33(3):405-413. PubMed ID: 29436728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDS research criteria for prodromal Parkinson's disease.
    Berg D; Postuma RB; Adler CH; Bloem BR; Chan P; Dubois B; Gasser T; Goetz CG; Halliday G; Joseph L; Lang AE; Liepelt-Scarfone I; Litvan I; Marek K; Obeso J; Oertel W; Olanow CW; Poewe W; Stern M; Deuschl G
    Mov Disord; 2015 Oct; 30(12):1600-11. PubMed ID: 26474317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal analyses of cerebrospinal fluid α-Synuclein in prodromal and early Parkinson's disease.
    Mollenhauer B; Caspell-Garcia CJ; Coffey CS; Taylor P; Singleton A; Shaw LM; Trojanowski JQ; Frasier M; Simuni T; Iranzo A; Oertel W; Siderowf A; Weintraub D; Seibyl J; Toga AW; Tanner CM; Kieburtz K; Chahine LM; Marek K; Galasko D;
    Mov Disord; 2019 Sep; 34(9):1354-1364. PubMed ID: 31361367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of the Movement Disorder Society prodromal criteria in healthy G2019S-LRRK2 carriers.
    Mirelman A; Saunders-Pullman R; Alcalay RN; Shustak S; Thaler A; Gurevich T; Raymond D; Mejia-Santana H; Orbe Reilly M; Ozelius L; Clark L; Gana-Weisz M; Bar-Shira A; Orr-Utreger A; Bressman SB; Marder K; Giladi N;
    Mov Disord; 2018 Jul; 33(6):966-973. PubMed ID: 29603409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study.
    Siderowf A; Concha-Marambio L; Lafontant DE; Farris CM; Ma Y; Urenia PA; Nguyen H; Alcalay RN; Chahine LM; Foroud T; Galasko D; Kieburtz K; Merchant K; Mollenhauer B; Poston KL; Seibyl J; Simuni T; Tanner CM; Weintraub D; Videnovic A; Choi SH; Kurth R; Caspell-Garcia C; Coffey CS; Frasier M; Oliveira LMA; Hutten SJ; Sherer T; Marek K; Soto C;
    Lancet Neurol; 2023 May; 22(5):407-417. PubMed ID: 37059509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prodromal Parkinson disease in patients with idiopathic hyposmia.
    Marrero-González P; Iranzo A; Bedoya D; Serradell M; Niñerola-Baizán A; Perissinotti A; Gaig C; Vilaseca I; Alobid I; Santamaría J; Mullol J
    J Neurol; 2020 Dec; 267(12):3673-3682. PubMed ID: 32676768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cross-sectional study of Parkinson's disease and the prodromal phase in community-dwelling older adults in eastern Japan.
    Taguchi K; Iwaoka K; Yamaguchi T; Nozaki R; Sato Y; Terauchi T; Suzuki Y; Takahashi K; Takahashi K; Akasaka H; Ishizuka N; Maeda T
    Clin Park Relat Disord; 2022; 7():100147. PubMed ID: 35647516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Criteria for Parkinson's Disease: From James Parkinson to the Concept of Prodromal Disease.
    Marsili L; Rizzo G; Colosimo C
    Front Neurol; 2018; 9():156. PubMed ID: 29628907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Externally validated deep learning model to identify prodromal Parkinson's disease from electrocardiogram.
    Karabayir I; Gunturkun F; Butler L; Goldman SM; Kamaleswaran R; Davis RL; Colletta K; Chinthala L; Jefferies JL; Bobay K; Ross GW; Petrovitch H; Masaki K; Tanner CM; Akbilgic O
    Sci Rep; 2023 Jul; 13(1):12290. PubMed ID: 37516770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orthostatic Hypotension: A Prodromal Marker of Parkinson's Disease?
    Dommershuijsen LJ; Heshmatollah A; Mattace Raso FUS; Koudstaal PJ; Ikram MA; Ikram MK
    Mov Disord; 2021 Jan; 36(1):164-170. PubMed ID: 32965064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update of the MDS research criteria for prodromal Parkinson's disease.
    Heinzel S; Berg D; Gasser T; Chen H; Yao C; Postuma RB;
    Mov Disord; 2019 Oct; 34(10):1464-1470. PubMed ID: 31412427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for prodromal Parkinson's disease in the general community: a sleep-based approach.
    Postuma RB; Pelletier A; Berg D; Gagnon JF; Escudier F; Montplaisir J
    Sleep Med; 2016 May; 21():101-5. PubMed ID: 27448479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution and clustering of prodromal parkinsonian features in GBA1 carriers.
    Mullin S; Beavan M; Bestwick J; McNeill A; Proukakis C; Cox T; Hughes D; Mehta A; Zetterberg H; Schapira AHV
    Mov Disord; 2019 Sep; 34(9):1365-1373. PubMed ID: 31251436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prodromal Parkinsonism and Neurodegenerative Risk Stratification in REM Sleep Behavior Disorder.
    Barber TR; Lawton M; Rolinski M; Evetts S; Baig F; Ruffmann C; Gornall A; Klein JC; Lo C; Dennis G; Bandmann O; Quinnell T; Zaiwalla Z; Ben-Shlomo Y; Hu MTM
    Sleep; 2017 Aug; 40(8):. PubMed ID: 28472425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.